Answers are grounded in this paper and cite their sources.
Cutaneous lupus erythematosus (CLE) is a heterogeneous autoimmune disease of the skin that commonly affects women of childbearing age. Some of the medications used in the treatment of CLE are safe in pregnancy, whereas others are contraindicated based on their teratogenic effects. We describe the most recent recommendations for the use of commonly prescribed CLE medications for those who are pregnant or plan on becoming pregnant.
No takes yet. Share an insight, caveat, or question.
Kirchner (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: